1.04
1.89%
-0.02
Handel nachbörslich:
1.09
0.05
+4.81%
Finanzdaten der Ovid Therapeutics Inc-Aktie (OVID)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
4.55%
0.148
|
0.1416 | 0.109 | 0.075 | 0.0662 |
Operating Expenses
|
4.17%
17.57
|
18.33 | 12.14 | 14.25 | 14.96 |
Benefits Costs and Expenses |
23.42%
11.84
|
15.46 | 11.36 | 12.48 | 13.42 |
Costs And Expenses |
23.42%
11.84
|
15.46 | 11.36 | 12.48 | 13.42 |
Operating Income/Loss |
4.24%
-17.42
|
-18.19 | -12.03 | -14.17 | -14.89 |
Income/Loss From Continuing Operations Before Tax |
-11.69
|
- | -11.25 | -12.41 | -13.36 |
Income Tax Expense/Benefit |
-
|
- | - | - | - |
Income/Loss From Continuing Operations After Tax |
-11.69
|
- | -11.25 | -12.41 | -13.36 |
Net Income/Loss
|
23.68%
-11.69
|
-15.32 | -11.25 | -12.41 | -13.36 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
195.97K%
70.72
|
0.0361 | 70.62 | 70.53 | 70.49 |
Diluted Average Shares |
195.97K%
70.72
|
0.0361 | 70.62 | 70.53 | 70.49 |
Basic Earnings Per Share |
22.73%
-0.17
|
-0.22 | -0.16 | -0.18 | -0.19 |
Diluted Earnings Per Share |
22.73%
-0.17
|
-0.22 | -0.16 | -0.18 | -0.19 |
Undistributed Earnings/Loss Allocated To Participating Securities, Basic |
-
|
- | - | - | - |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):